Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 397 entries
Sorted by: Best Match Show Resources per page
Elucidating semantic disorganization from word comprehension: do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?.

Acta neuropsychiatrica

Batty R, Rossell S.
PMID: 27397253
Acta Neuropsychiatr. 2006 Dec;18(6):277-8. doi: 10.1017/S0924270800030957.

No abstract available.

Cite
Batty R, Rossell S. Elucidating semantic disorganization from word comprehension: do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?. Acta Neuropsychiatr. 2006;18(6):277-8doi: 10.1017/S0924270800030957.
Batty, R., & Rossell, S. (2006). Elucidating semantic disorganization from word comprehension: do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?. Acta neuropsychiatrica, 18(6), 277-8. https://doi.org/10.1017/S0924270800030957
Batty, R, and Rossell, S. "Elucidating semantic disorganization from word comprehension: do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?." Acta neuropsychiatrica vol. 18,6 (2006): 277-8. doi: https://doi.org/10.1017/S0924270800030957
Batty R, Rossell S. Elucidating semantic disorganization from word comprehension: do patients with schizophrenia and bipolar disorder show differential processing of nouns, verbs and adjectives?. Acta Neuropsychiatr. 2006 Dec;18(6):277-8. doi: 10.1017/S0924270800030957. PMID: 27397253.
Copy Download .nbib Format: NLM
Predicting resistance by selection of signaling pathways.

Translational lung cancer research

Karachaliou N, Rosell R, Molina MA, Viteri S.
PMID: 25806289
Transl Lung Cancer Res. 2014 Apr;3(2):107-15. doi: 10.3978/j.issn.2218-6751.2014.02.04.

Epidermal growth factor receptor (EGFR) mutations occur in 17% of non-small-cell lung cancer (NSCLC) patients with notable response to single agent therapy but with low complete remission rate and, eventually, disease progression. Priming BIM, a pro-apoptotic signaling BH3-only protein,...

Cite
Karachaliou N, Rosell R, Molina MA, et al. Predicting resistance by selection of signaling pathways. Transl Lung Cancer Res. 2014;3(2):107-15doi: 10.3978/j.issn.2218-6751.2014.02.04.
Karachaliou, N., Rosell, R., Molina, M. A., & Viteri, S. (2014). Predicting resistance by selection of signaling pathways. Translational lung cancer research, 3(2), 107-15. https://doi.org/10.3978/j.issn.2218-6751.2014.02.04
Karachaliou, Niki, et al. "Predicting resistance by selection of signaling pathways." Translational lung cancer research vol. 3,2 (2014): 107-15. doi: https://doi.org/10.3978/j.issn.2218-6751.2014.02.04
Karachaliou N, Rosell R, Molina MA, Viteri S. Predicting resistance by selection of signaling pathways. Transl Lung Cancer Res. 2014 Apr;3(2):107-15. doi: 10.3978/j.issn.2218-6751.2014.02.04. PMID: 25806289; PMCID: PMC4367662.
Copy Download .nbib Format: NLM
ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation.

Translational lung cancer research

Karachaliou N, Gimenez-Capitan A, Drozdowskyj A, Viteri S, Moran T, Carcereny E, Massuti B, Vergnenegre A, de Marinis F, Molina MA, Teixido C, Rosell R.
PMID: 25806291
Transl Lung Cancer Res. 2014 Jun;3(3):122-30. doi: 10.3978/j.issn.2218-6751.2014.03.02.

BACKGROUND: Activation of bypass signaling pathways, impairment of apoptosis and mutation of epidermal growth factor receptor (EGFR) to a drug-resistant state are well known mechanisms of resistance to single-agent erlotinib therapy in non-small-cell lung cancer (NSCLC) driven by EGFR...

Cite
Karachaliou N, Gimenez-Capitan A, Drozdowskyj A, et al. ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation. Transl Lung Cancer Res. 2014;3(3):122-30doi: 10.3978/j.issn.2218-6751.2014.03.02.
Karachaliou, N., Gimenez-Capitan, A., Drozdowskyj, A., Viteri, S., Moran, T., Carcereny, E., Massuti, B., Vergnenegre, A., de Marinis, F., Molina, M. A., Teixido, C., & Rosell, R. (2014). ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation. Translational lung cancer research, 3(3), 122-30. https://doi.org/10.3978/j.issn.2218-6751.2014.03.02
Karachaliou, Niki, et al. "ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation." Translational lung cancer research vol. 3,3 (2014): 122-30. doi: https://doi.org/10.3978/j.issn.2218-6751.2014.03.02
Karachaliou N, Gimenez-Capitan A, Drozdowskyj A, Viteri S, Moran T, Carcereny E, Massuti B, Vergnenegre A, de Marinis F, Molina MA, Teixido C, Rosell R. ROR1 as a novel therapeutic target for EGFR-mutant non-small-cell lung cancer patients with the EGFR T790M mutation. Transl Lung Cancer Res. 2014 Jun;3(3):122-30. doi: 10.3978/j.issn.2218-6751.2014.03.02. PMID: 25806291; PMCID: PMC4367691.
Copy Download .nbib Format: NLM
Olfaction: An Overlooked Sensory Modality in Applied Ethology and Animal Welfare.

Frontiers in veterinary science

Nielsen BL, Jezierski T, Bolhuis JE, Amo L, Rosell F, Oostindjer M, Christensen JW, McKeegan D, Wells DL, Hepper P.
PMID: 26664995
Front Vet Sci. 2015 Dec 03;2:69. doi: 10.3389/fvets.2015.00069. eCollection 2015.

No abstract available.

Cite
Nielsen BL, Jezierski T, Bolhuis JE, et al. Olfaction: An Overlooked Sensory Modality in Applied Ethology and Animal Welfare. Front Vet Sci. 2015;2:69doi: 10.3389/fvets.2015.00069.
Nielsen, B. L., Jezierski, T., Bolhuis, J. E., Amo, L., Rosell, F., Oostindjer, M., Christensen, J. W., McKeegan, D., Wells, D. L., & Hepper, P. (2015). Olfaction: An Overlooked Sensory Modality in Applied Ethology and Animal Welfare. Frontiers in veterinary science, 269. https://doi.org/10.3389/fvets.2015.00069
Nielsen, Birte L, et al. "Olfaction: An Overlooked Sensory Modality in Applied Ethology and Animal Welfare." Frontiers in veterinary science vol. 2 (2015): 69. doi: https://doi.org/10.3389/fvets.2015.00069
Nielsen BL, Jezierski T, Bolhuis JE, Amo L, Rosell F, Oostindjer M, Christensen JW, McKeegan D, Wells DL, Hepper P. Olfaction: An Overlooked Sensory Modality in Applied Ethology and Animal Welfare. Front Vet Sci. 2015 Dec 03;2:69. doi: 10.3389/fvets.2015.00069. eCollection 2015. PMID: 26664995; PMCID: PMC4672279.
Copy Download .nbib Format: NLM
Structure of liquid Y3Al5O12 (YAG).

Physical review letters

Weber JK, Krishnan S, Ansell S, Hixson AD, Nordine PC.
PMID: 11019161
Phys Rev Lett. 2000 Apr 17;84(16):3622-5. doi: 10.1103/PhysRevLett.84.3622.

The total structure factor S(Q) and the radial distribution function G(r) of liquid Y3Al5O12 (YAG) were measured at 1770-2230 K by x-ray scattering from samples under containerless conditions in Ar and O2. Nominal coordination numbers are 4 for Al3+...

Cite
Weber JK, Krishnan S, Ansell S, et al. Structure of liquid Y3Al5O12 (YAG). Phys Rev Lett. 2000;84(16):3622-5doi: 10.1103/PhysRevLett.84.3622.
Weber, J. K., Krishnan, S., Ansell, S., Hixson, A. D., & Nordine, P. C. (2000). Structure of liquid Y3Al5O12 (YAG). Physical review letters, 84(16), 3622-5. https://doi.org/10.1103/PhysRevLett.84.3622
Weber, et al. "Structure of liquid Y3Al5O12 (YAG)." Physical review letters vol. 84,16 (2000): 3622-5. doi: https://doi.org/10.1103/PhysRevLett.84.3622
Weber JK, Krishnan S, Ansell S, Hixson AD, Nordine PC. Structure of liquid Y3Al5O12 (YAG). Phys Rev Lett. 2000 Apr 17;84(16):3622-5. doi: 10.1103/PhysRevLett.84.3622. PMID: 11019161.
Copy Download .nbib Format: NLM
[INTESTINAL CYSTIC PNEUMATOSIS: REPORT OF A CASE].

Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru

Guzmán M, Rosell V, Cantera R, Guzmán V, Cadillo M, Amaya N, Aldave A.
PMID: 12140602
Rev Gastroenterol Peru. 2000 Apr-Jun;20(2):173-177.

We present a case of serous cystic pneumatosis of the small intestine, infrequently clinical entity. The case is commented and it revises the literature.

Cite
Guzmán M, Rosell V, Cantera R, et al. Neumatosis quística intestinal:Reporte de un caso clínico y revisión de la literatura. [INTESTINAL CYSTIC PNEUMATOSIS: REPORT OF A CASE]. Rev Gastroenterol Peru. 2000;20(2):173-177
Guzmán, M., Rosell, V., Cantera, R., Guzmán, V., Cadillo, M., Amaya, N., & Aldave, A. (2000). Neumatosis quística intestinal:Reporte de un caso clínico y revisión de la literatura. [INTESTINAL CYSTIC PNEUMATOSIS: REPORT OF A CASE]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru, 20(2), 173-177.
Guzmán, María, et al. "Neumatosis quística intestinal:Reporte de un caso clínico y revisión de la literatura." [INTESTINAL CYSTIC PNEUMATOSIS: REPORT OF A CASE]. Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru vol. 20,2 (2000): 173-177.
Guzmán M, Rosell V, Cantera R, Guzmán V, Cadillo M, Amaya N, Aldave A. Neumatosis quística intestinal:Reporte de un caso clínico y revisión de la literatura. [INTESTINAL CYSTIC PNEUMATOSIS: REPORT OF A CASE]. Rev Gastroenterol Peru. 2000 Apr-Jun;20(2):173-177. Spanish. PMID: 12140602.
Copy Download .nbib Format: NLM
Combining marks, scores and grades. Reviewing common practices reveals some bad habits.

Medical education

Fowell S, Jolly B.
PMID: 11012925
Med Educ. 2000 Oct;34(10):785-6. doi: 10.1046/j.1365-2923.2000.00796.x.

No abstract available.

Cite
Fowell S, Jolly B. Combining marks, scores and grades. Reviewing common practices reveals some bad habits. Med Educ. 2000;34(10):785-6doi: 10.1046/j.1365-2923.2000.00796.x.
Fowell, S., & Jolly, B. (2000). Combining marks, scores and grades. Reviewing common practices reveals some bad habits. Medical education, 34(10), 785-6. https://doi.org/10.1046/j.1365-2923.2000.00796.x
Fowell, S, and Jolly, B. "Combining marks, scores and grades. Reviewing common practices reveals some bad habits." Medical education vol. 34,10 (2000): 785-6. doi: https://doi.org/10.1046/j.1365-2923.2000.00796.x
Fowell S, Jolly B. Combining marks, scores and grades. Reviewing common practices reveals some bad habits. Med Educ. 2000 Oct;34(10):785-6. doi: 10.1046/j.1365-2923.2000.00796.x. PMID: 11012925.
Copy Download .nbib Format: NLM
Investigation of undercooled liquid metals using XAFS, temperature scans and diffraction.

Journal of synchrotron radiation

Filipponi A, Di Cicco A, De Panfilis S, Trapananti A, Itiè JP, Borowski M, Ansell S.
PMID: 11512940
J Synchrotron Radiat. 2001 Mar 01;8:81-6. doi: 10.1107/s0909049500019300.

Novel techniques and the experimental station for experiments on condensed matter under extreme conditions that have been developed at the BM29 beamline of the European Synchrotron Radiation Facility (ESRF) are described. The experimental setup includes facilities to collect high-quality...

Cite
Filipponi A, Di Cicco A, De Panfilis S, et al. Investigation of undercooled liquid metals using XAFS, temperature scans and diffraction. J Synchrotron Radiat. 2001;8:81-6doi: 10.1107/s0909049500019300.
Filipponi, A., Di Cicco, A., De Panfilis, S., Trapananti, A., Itiè, J. P., Borowski, M., & Ansell, S. (2001). Investigation of undercooled liquid metals using XAFS, temperature scans and diffraction. Journal of synchrotron radiation, 881-6. https://doi.org/10.1107/s0909049500019300
Filipponi, A, et al. "Investigation of undercooled liquid metals using XAFS, temperature scans and diffraction." Journal of synchrotron radiation vol. 8 (2001): 81-6. doi: https://doi.org/10.1107/s0909049500019300
Filipponi A, Di Cicco A, De Panfilis S, Trapananti A, Itiè JP, Borowski M, Ansell S. Investigation of undercooled liquid metals using XAFS, temperature scans and diffraction. J Synchrotron Radiat. 2001 Mar 01;8:81-6. doi: 10.1107/s0909049500019300. PMID: 11512940.
Copy Download .nbib Format: NLM
[Not Available].

Revue de chirurgie orthopedique et reparatrice de l'appareil moteur

Plaweski S, Rosell P, Rossi J, Benhyahia H, Merloz P, Julliard R.
PMID: 16609596
Rev Chir Orthop Reparatrice Appar Mot. 2005 Dec;91:73. doi: 10.1016/s0035-1040(05)84551-9.

No abstract available.

Cite
Plaweski S, Rosell P, Rossi J, et al. Reconstruction anatomique du LCA: évaluation anatomométrique. [Not Available]. Rev Chir Orthop Reparatrice Appar Mot. 2005;91:73doi: 10.1016/s0035-1040(05)84551-9.
Plaweski, S., Rosell, P., Rossi, J., Benhyahia, H., Merloz, P., & Julliard, R. (2005). Reconstruction anatomique du LCA: évaluation anatomométrique. [Not Available]. Revue de chirurgie orthopedique et reparatrice de l'appareil moteur, 9173. https://doi.org/10.1016/s0035-1040(05)84551-9
Plaweski, S, et al. "Reconstruction anatomique du LCA: évaluation anatomométrique." [Not Available]. Revue de chirurgie orthopedique et reparatrice de l'appareil moteur vol. 91 (2005): 73. doi: https://doi.org/10.1016/s0035-1040(05)84551-9
Plaweski S, Rosell P, Rossi J, Benhyahia H, Merloz P, Julliard R. Reconstruction anatomique du LCA: évaluation anatomométrique. [Not Available]. Rev Chir Orthop Reparatrice Appar Mot. 2005 Dec;91:73. doi: 10.1016/s0035-1040(05)84551-9. French. PMID: 16609596.
Copy Download .nbib Format: NLM
A route to the brightest possible neutron source?.

Science (New York, N.Y.)

Taylor A, Dunne M, Bennington S, Ansell S, Gardner I, Norreys P, Broome T, Findlay D, Nelmes R.
PMID: 17322053
Science. 2007 Feb 23;315(5815):1092-5. doi: 10.1126/science.1127185.

We review the potential to develop sources for neutron scattering science and propose that a merger with the rapidly developing field of inertial fusion energy could provide a major step-change in performance. In stark contrast to developments in synchrotron...

Cite
Taylor A, Dunne M, Bennington S, et al. A route to the brightest possible neutron source?. Science. 2007;315(5815):1092-5doi: 10.1126/science.1127185.
Taylor, A., Dunne, M., Bennington, S., Ansell, S., Gardner, I., Norreys, P., Broome, T., Findlay, D., & Nelmes, R. (2007). A route to the brightest possible neutron source?. Science (New York, N.Y.), 315(5815), 1092-5. https://doi.org/10.1126/science.1127185
Taylor, Andrew, et al. "A route to the brightest possible neutron source?." Science (New York, N.Y.) vol. 315,5815 (2007): 1092-5. doi: https://doi.org/10.1126/science.1127185
Taylor A, Dunne M, Bennington S, Ansell S, Gardner I, Norreys P, Broome T, Findlay D, Nelmes R. A route to the brightest possible neutron source?. Science. 2007 Feb 23;315(5815):1092-5. doi: 10.1126/science.1127185. PMID: 17322053.
Copy Download .nbib Format: NLM
Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke.

Biomarker insights

Allard L, Turck N, Burkhard PR, Walter N, Rosell A, Gex-Fabry M, Hochstrasser DF, Montaner J, Sanchez JC.
PMID: 19662200
Biomark Insights. 2007 Apr 19;2:155-64.

BACKGROUND: Efficacy of thrombolysis in acute ischemic stroke is strongly related to physician's ability to make an accurate diagnosis and to intervene within 3-6 h after event onset. In this context, the discovery and validation of very early blood...

Cite
Allard L, Turck N, Burkhard PR, et al. Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomark Insights. 2007;2:155-64
Allard, L., Turck, N., Burkhard, P. R., Walter, N., Rosell, A., Gex-Fabry, M., Hochstrasser, D. F., Montaner, J., & Sanchez, J. C. (2007). Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomarker insights, 2155-64.
Allard, Laure, et al. "Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke." Biomarker insights vol. 2 (2007): 155-64.
Allard L, Turck N, Burkhard PR, Walter N, Rosell A, Gex-Fabry M, Hochstrasser DF, Montaner J, Sanchez JC. Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke. Biomark Insights. 2007 Apr 19;2:155-64. PMID: 19662200; PMCID: PMC2717829.
Copy Download .nbib Format: NLM
Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients.

Clinical lung cancer

Camps C, Sarries C, Roig B, Sanchez JJ, Queralt C, Sancho E, Martinez N, Tarón M, Rosell R.
PMID: 14624713
Clin Lung Cancer. 2003 Jan;4(4):237-41. doi: 10.3816/clc.2003.n.004.

Only about one third of non-small-cell lung cancer (NSCLC) patients respond to cisplatin-based chemotherapy. Cisplatin DNA adducts are commonly repaired through the nucleotide excision repair pathway. The study of rare inherited disorders such as xeroderma pigmentosum and Cockayne syndrome...

Cite
Camps C, Sarries C, Roig B, et al. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2003;4(4):237-41doi: 10.3816/clc.2003.n.004.
Camps, C., Sarries, C., Roig, B., Sanchez, J. J., Queralt, C., Sancho, E., Martinez, N., Tarón, M., & Rosell, R. (2003). Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clinical lung cancer, 4(4), 237-41. https://doi.org/10.3816/clc.2003.n.004
Camps, Carlos, et al. "Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients." Clinical lung cancer vol. 4,4 (2003): 237-41. doi: https://doi.org/10.3816/clc.2003.n.004
Camps C, Sarries C, Roig B, Sanchez JJ, Queralt C, Sancho E, Martinez N, Tarón M, Rosell R. Assessment of nucleotide excision repair XPD polymorphisms in the peripheral blood of gemcitabine/cisplatin-treated advanced non-small-cell lung cancer patients. Clin Lung Cancer. 2003 Jan;4(4):237-41. doi: 10.3816/clc.2003.n.004. PMID: 14624713.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 397 entries